SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,209 | -26.7% | 21,386 | -1.8% | 0.00% | – |
| Q2 2023 | $101,287 | +12.8% | 21,782 | +12.0% | 0.00% | – |
| Q1 2023 | $89,826 | -82.3% | 19,443 | -69.0% | 0.00% | – |
| Q4 2022 | $506,939 | +54.1% | 62,740 | +5.8% | 0.00% | – |
| Q3 2022 | $329,000 | +2.8% | 59,302 | -3.3% | 0.00% | – |
| Q2 2022 | $320,000 | -28.1% | 61,318 | +13.3% | 0.00% | – |
| Q1 2022 | $445,000 | -82.0% | 54,131 | -67.4% | 0.00% | -100.0% |
| Q4 2021 | $2,474,000 | -62.1% | 166,222 | -51.9% | 0.00% | -50.0% |
| Q3 2021 | $6,520,000 | +4.3% | 345,237 | +2.7% | 0.00% | 0.0% |
| Q2 2021 | $6,252,000 | -6.3% | 336,290 | +14.8% | 0.00% | 0.0% |
| Q1 2021 | $6,670,000 | +357.2% | 293,033 | +336.1% | 0.00% | – |
| Q4 2020 | $1,459,000 | – | 67,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |